This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Yangtze River Pharmaceutical Group Co., Ltd.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Lianyong Shi: Innovator in Pharmaceutical Development
Introduction
Lianyong Shi is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on yonkenafil hydrochloride. His expertise and dedication to research have led to the development of valuable intellectual property.
Latest Patents
Lianyong Shi holds a patent for a polymorphic substance of yonkenafil hydrochloride, along with its preparation method, composition, and use. The patent describes an A-type polymorphic substance characterized by a specific powder diffraction pattern. This pattern includes diffraction peaks at various 2θ values, which are crucial for identifying the substance's unique properties.
Career Highlights
Lianyong Shi is associated with Yangtze River Pharmaceutical Group Co., Ltd., where he has been instrumental in advancing pharmaceutical research and development. His work has not only contributed to the company's portfolio but has also enhanced the understanding of polymorphic substances in drug formulation.
Collaborations
Lianyong Shi has collaborated with esteemed colleagues such as Haibo Zhang and Lingwu Chen. Their combined efforts have fostered a productive research environment, leading to innovative solutions in the pharmaceutical industry.
Conclusion
Lianyong Shi's contributions to the field of pharmaceuticals, particularly through his patent on yonkenafil hydrochloride, highlight his role as an influential inventor. His work continues to impact the industry positively, showcasing the importance of innovation in drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile